Abstract

BackgroundThe aim was to assess the risk of venous thromboembolism (VTE) associated with use of combined oral contraceptives (COCs) in women with a family history of VTE.MethodsThe study is a Swedish nationwide case-control study based on the Multigeneration register, the Swedish Hospital Discharge Register, the Outpatient Care Register, and the Swedish Prescribed Drug Register. Cases (n = 2,311) were non-pregnant Swedish women aged 15-49 with first VTE diagnoses between January 2006 and December 2010. Five controls without VTE were matched to each case on age and education level. Conditional logistic regression examined the associations with VTE with determination of odds ratio (OR) for first VTE diagnosis. Effect modification was assessed by interaction testing.ResultsBoth among controls (14.6 % vs. 4.5 %; p < 0.0001) and cases (27.2 % vs. 8.8 %; p < 0.0001) COC use was more common in women without a family history of VTE compared with women with a family history of VTE. In a multivariate conditional logistic regression model the OR for VTE was 2.53 (95 % CI 2.23-2.87) for COC users and 2.38 (2.09-2.71) for individuals with a family history of VTE. The OR for VTE for COC users with a family history of VTE was 6.02 (5.02-7.22). There was no significant interaction between family history of VTE and COC use (OR 0.92, 0.57-1.46).ConclusionsFamily history of VTE is a risk factor for VTE in women using COCs. The low prevalence of COC use among women with a family history of VTE suggests that family history of VTE is considered when COCs are prescribed in Sweden. The present study may therefore even underestimate the importance of family history of VTE. The lack of interaction indicates that the risk of COC use in women with family history of VTE is determined by the product of the ORs for family history and COC use.Electronic supplementary materialThe online version of this article (doi:10.1186/s12959-015-0065-x) contains supplementary material, which is available to authorized users.

Highlights

  • The first report of an increased risk of venous thrombosis associated with oral contraceptives appeared in 1961 [1]

  • In models A1 and A2 we separately investigated the effects of contraceptives and family history of venous thromboembolism (VTE) on VTE, respectively

  • The mean age of cases was 36.4 years. Both among controls (14.6 % vs. 4.5 %; p

Read more

Summary

Introduction

The first report of an increased risk of venous thrombosis associated with oral contraceptives appeared in 1961 [1]. Zöller et al Thrombosis Journal (2015) 13:34 significantly increased health risks Recognizing this increased VTE risk, WHO recommends against use of COCs among women with these conditions. Several reports have investigated whether family history of VTE could be used to identify women with thrombophilic defects, but the sensitivity and specificity of finding thrombophilic defects are too low [28, 29]. Bezemar found that only 30 % of patients with a family history of VTE have an identified thrombophilic defect [30]. The aim was to assess the risk of venous thromboembolism (VTE) associated with use of combined oral contraceptives (COCs) in women with a family history of VTE

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call